Primary Record
inosine
- In stock
- 5,251 g
- Purity
- 98.4 %
- CAS
- 58-63-9
Compound Identifiers & Properties
- CAS
- 58-63-9
- PubChem CID
- 135398641
- SMILES
- C1=NC2=C(C(=O)N1)N=CN2[C@H]3[C@@H]([C@@H]([C@H](O3)CO)O)O
- Canonical SMILES
- O=c1[nH]cnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O
Names & Synonyms
- inosine
- Hypoxanthosine
- Ribonosine
- Oxiamin
- Atorel
- Trophicardyl
- Selfer
- Hypoxanthine riboside
- Panholic-L
- beta-Inosine
- Pantholic-L
- 58-63-9
- Inosina
- Hypoxanthine D-riboside
- Inosinum
- Inosie
- Inotin
- (-)-Inosine
- Hypoxanthine nucleoside
- iso-prinosine
- Hypoxanthine ribonucleoside
- riboxine
- Inosin
- 9-beta-D-Ribofuranosylhypoxanthine
- hypoxanthine-ribose
- Carnine
- Catacol
- Hypoxanthosine;
- Trophicardyl;
- inosin-
- Inosine [INN:JAN]
- Oxiamine;
- Inosine-
- Inosinum [INN-Latin]
- 3h-inosine
- D-Inosine
- Inosie;
- L-Inosine
- Inosina [INN-Spanish]
- .beta.-Inosine
- 2ada
- 2fqw
- INO 495
- Inotin (TN)
- Hypoxanthine riboside;
- Inosine (JAN/INN)
- Hypoxanthine arabinoside
- 1a4m
- DTXSID2045993
- Adenosine EP Impurity G
- Inosine (8CI,9CI)
- INOSINE [INN]
- INOSINE [JAN]
- AC1L1LMO
- INOSINE [MI]
- INOSINE [MART.]
- Opera_ID_1628
- RefChem:791048
- Hypoxanthine ribonucleosido
- UGQMRVRMYYASKQ-KQYNXXCUSA-N
- C10H12N4O5
- INOSINE [WHO-DD]
- INOSINE [WHO-IP]
- MFCD00066770
- bmse000098
- bmse000888
- bmse000978
- UNII-5A614L51CT
- cid_6021
- Hypoxanthine, 9-beta-D-ribofuranosyl-
- MLS000028518
- Hypoxanthine-9-beta-D-ribofuranoside
- 5A614L51CT
- CHEMBL1556
- NSC 20262
- SCHEMBL15804
- beta-D-Ribofuranoside, hypoxanthine-9
- DTXCID0025993
- KBioGR_002560
- KBioSS_002569
- CHEBI:17596
- KSC269S6L
- ARONIS24558
- EINECS 200-390-4
- Hypoxanthine 9-beta-D-ribofuranoside
- INDOLE-3-CARBOXALDEHYDE
- INOSINE [USP IMPURITY]
- NSC-20262
- AC1Q77T9
- AI3-52241
- GTPL4554
- SCHEMBL1682742
- SCHEMBL3365586
- SCHEMBL6933022
- 9-b-D-Ribofuranosylhypoxanthine
- Hypoxanthine-9-D-ribofuranoside
- Inosine, >=99% (HPLC)
- 9.beta.-D-Ribofuranosylhypoxanthine
- INO-1001
- SCHEMBL18653532
- 9-beta-D-ribofuranosyl-9H-purin-6-ol
- 9beta-D-Ribofuranosylhypoxanthine
- BDBM22104
- CTK1G9965
- ERK5-6N10
- KBio2_002560
- KBio2_005128
- KBio2_007696
- KBio3_003038
- 9-|A-D-Ribofuranosylhypoxanthine
- 9-b-D-ribofuranosyl-Hypoxanthine
- CID6021
- D06BB05
- G01AX02
- INOSINE (REFERENCE GRADE)
- MSK6812
- S01XA10
- 9-.beta.-D-Ribofuranosylhypoxanthine
- 9-|_-D-Ribofuranosylhypoxanthine
- cMAP_000084
- HMS2235I17
- Inosine 99% for biochemistry 5gm
- Hypoxanthine-9-delta-ribofuranoside
- 9-beta-D-ribofuranosyl-Hypoxanthine
- AMY30713
- HY-N0092
- Hypoxanthine 9-|A-D-ribofuranoside
- NSC20262
- ZINC8855117
- 9beta-delta-Ribofuranosylhypoxanthine
- CID 5274258
- Tox21_111522
- AN-889
- ANW-33000
- BDBM50366815
- beta-D-Ribofuranoside hypoxanthine-9
- EBC-44242
- EBC-47437
- hypoxanthine-9 beta-D-Ribofuranoside
- MFCD22689457
- NP0572
- s2442
- 9-beta-delta-Ribofuranosylhypoxanthine
- SMR000058316
- AKOS015969695
- AKOS015995607
- AKOS024462561
- Atorel; HXR; Hypoxanthine D-riboside
- C10-H12-N4-O5
- Inosine, 99% - 100G 100g
- Tox21_111522_1
- 9-beta-delta-ribofuranosyl-Hypoxanthine
- AM83935
- CCG-267127
- CS-5845
- DB04335
- DIDANOSINE IMPURITY B [WHO-IP]
- J1.388I
- NI06297
- RTR-037177
- beta-delta-Ribofuranoside hypoxanthine-9
- CAS-58-63-9
- Hypoxanthine 9-beta-delta-ribofuranoside
- hypoxanthine-9 beta-delta-Ribofuranoside
- Hypoxanthine-9-beta-delta-ribofuranoside
- INO
- SMP1_000165
- .beta.-D-Ribofuranoside, hypoxanthine-9
- NCGC00095787-01
- NCGC00095787-05
- NCGC00095787-06
- NCGC00096119-02
- NCGC00096119-03
- AS-11754
- BP-51105
- CJ-13587
- Hypoxanthine, 9-.beta.-D-ribofuranosyl-
- LS-84000
- SY005000
- 9-(beta-D-ribofuranosyl)-9H-purin-6-ol
- ADENOSINE IMPURITY G [EP IMPURITY]
- CID:135398641
- SID:134224896
- 1,9-Dihydro-9-beta-D-ribofuranosyl-6H-purin-6-one
- 9-(beta-D-Ribofuranosyl)-9H-purine-6-ol
- AB0066076
- AB1000320
- DB-029916
- DIDANOSINE IMPURITY B [EP IMPURITY]
- HXR
- TR-037177
- B3677
- I0037
- NS00010210
- Inosine (<lt/> 100 microg/ml) in methanol
- A-8687
- C00294
- D00054
- EN300-310328
- J10406
- 1,9-dihydro-9-b-D-ribofuranosyl-6H-Purin-6-one
- A831960
- D007288
- Q422564
- SR-01000721862
- (-)-Inosine, Hypoxanthine 9-beta-D-ribofuranoside
- 9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-1H-purin-6-one
- SR-01000721862-2
- SR-01000721862-3
- 9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6,9-dihydro-1H-purin-6-one
- 9-beta-D-Ribofuranosyl-1,6-dihydro-9H-purine-6-one
- AC89F8E4-FD89-45EE-8B41-94DFC07AB42F
- BRD-K79612754-001-19-1
- BRD-K79612754-001-21-7
- 1,9-Dihydro-9-beta-delta-ribofuranosyl-6H-purin-6-one
- 6H-Purin-6-one, 1,9-dihydro-9-beta-D-ribofuranosyl-
- 9-beta-D-Ribofuranosyl-1,9-dihydro-6H-purin-6-one (Inosine)
- Z2681890654
- 9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1H-purin-6(9H)-one
- Inosine; Adenosine EP Impurity G; Didanosine EP Impurity B
- (2R,3S,4R,5R)-2-(hydroxymethyl)-5-(6-hydroxypurin-9-yl)oxolane-3,4-diol
- 9-.BETA.-D-RIBOFURANOSYL-1,9-DIHYDRO-6H-PURIN-6-ONE
- (2R,3R,4S,5R)-2-(6-Hydroxy-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol
- 9-((2R,3R,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-3H-purin-6(9H)-one
- 9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6,9-dihydro-3H-purin-6-one
- 9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-3H-purin-6-one
- 9-.BETA.-D-RIBOFURANOSYL-1,9-DIHYDRO-6H-PURIN-6-ONE [WHO-IP]
- NOS
- (2R,3R,4S,5R)-2-(6-hydroxy-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
- (2R,3S,4R,5R)-2-(hydroxymethyl)-5-(6-hydroxy-9H-purin-9-yl)tetrahydrofuran-3,4-diol
- 9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl)-1H-purin-6-one
- 9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl)-3H-purin-6-one
- 9-(3,4-DIHYDROXY-5-HYDROXYMETHYL-TETRAHYDRO-FURAN-2-YL)-1,9-DIHYDRO-PURIN-6-ONE
- 9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H-purin-6-one
- 9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1H-purin-6-one
- 200-390-4
- 21138-24-9
- 478182-32-0
- 9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl)-6,9-dihydro-1H-purin-6-one
- 9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl)-6,9-dihydro-3H-purin-6-one
- 9-[(2S,5S)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-1,9-dihydro-6H-purin-6-one
- 9-|A-D-Ribofuranosylhypoxanthine; 9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-1,9-dihydro-6H-purin-6-one
- Adenosine Imp. G (EP); Inosine; Didanosine Imp. B (Ph. Int.); 9-beta-D-Ribofuranosyl-1,9-dihydro-6H-purin-6-one; Adenosine Impurity G; Didanosine Impurity B
- InChI=1/C10H12N4O5/c15-1-4-6(16)7(17)10(19-4)14-3-13-5-8(14)11-2-12-9(5)18/h2-4,6-7,10,15-17H,1H2,(H,11,12,18)/t4-,6-,7-,10-/m1/s